No photo of Emanuelle Araujo Lima Bellaguarda

View Scopus Profile

Emanuelle Araujo Lima Bellaguarda

  • 211 Citations
20072023

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Inflammatory bowel disease (Crohn's disease and ulcerative colitis), therapeutic drug monitoring, clinical trials

Training Experience

2011Residency, Boston University Medical Center
2014Fellowship, University of Chicago
2015Fellowship, Northwestern University, Feinberg School of Medicine

Education/Academic qualification

MD, Federal University of Ceara

… → 2006

Research interests

  • Inflammatory Bowel Disease

Fingerprint Dive into the research topics where Emanuelle Araujo Lima Bellaguarda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

Bellaguarda, E. A. L.

DrugDev Inc., Arena Pharmaceuticals, Inc.

5/11/20 → 5/11/23

Project: Research project

Prot#M16-006: A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease (M16-006)

Bellaguarda, E. A. L.

AbbVie Inc.

7/23/19 → 7/22/22

Project: Research project

Protocol M14-234: A Multicenter, Randomized, Double-Blind, Placebo -Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Bellaguarda, E. A. L. & Hanauer, S. B.

AbbVie Inc.

7/23/19 → 7/23/22

Project: Research project

Protocol M16-000: A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006

Bellaguarda, E. A. L.

AbbVie Inc.

7/1/19 → 3/4/23

Project: Research project

Semen quality in males with inflammatory bowel disease and inflammatory joint disease: Influence of ustekinumab and tofacitinib treatment

Bellaguarda, E. A. L.

Northwestern Memorial Hospital, Digestive Health Foundation

7/1/19 → 6/30/20

Project: Research project

Research Output

  • 211 Citations
  • 10 Article
  • 2 Review article
  • 1 Letter

Checkpoint Inhibitor-Induced Colitis

Bellaguarda, E. & Hanauer, S., Feb 1 2020, In : The American journal of gastroenterology. 115, 2, p. 202-210 9 p.

Research output: Contribution to journal › Article

Open Access

    • Disordered Eating, Body Dissatisfaction, and Psychological Distress in Patients with Inflammatory Bowel Disease (IBD)

    Wabich, J., Bellaguarda, E., Joyce, C., Keefer, L. & Kinsinger, S., Jun 1 2020, In : Journal of Clinical Psychology in Medical Settings. 27, 2, p. 310-317 8 p.

    Research output: Contribution to journal › Article

    • Recurrent brisk haematochezia in a patient with quiescent Crohn's disease

    Gasanova, Z., Lemmer, A. & Bellaguarda, E., Jan 1 2020, (Accepted/In press) In : Frontline Gastroenterology. flgastro-2019-101404.

    Research output: Contribution to journal › Article

    Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis

    Limketkai, B. N., Shah, S. C., Hirano, I., Bellaguarda, E. & Colombel, J. F., Dec 1 2019, In : Gut. 68, 12, p. 2152-2160 9 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

    Christensen, B., Micic, D., Gibson, P. R., Yarur, A., Bellaguarda, E., Corsello, P., Gaetano, J. N., Kinnucan, J., Rao, V. L., Reddy, S., Singh, S., Pekow, J. & Rubin, D. T., Mar 2018, In : Alimentary Pharmacology and Therapeutics. 47, 6, p. 753-762 10 p.

    Research output: Contribution to journal › Article

    • 28 Scopus citations